Information Provided By:
Fly News Breaks for February 6, 2017
ATHN
Feb 6, 2017 | 07:04 EDT
KeyBanc says that athenahealth's stock is attractive following its pullback. The firm believes that the company's Q4 revenue miss was caused by "a macro anomaly with unusually weak physician activity in the quarter." It remains upbeat on the company's fundamentals, predicting that its EBITDA growth will be 20%+ over the longer term. KeyBanc keeps a $140 price target and an Overweight rating on the shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN